Tadalafil is a selective phosphodiesterase-5 inhibitor that is used to treat erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy. It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH. It is grouped under the following drug class(es): PDE5 Inhibitors and Vasodilating agents. Its therapeutic use is listed as sexual dysfunction agents and urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cialis and Tadalafil mylan. Its PubChem CID is 110635.
Tadalafil
| CAS No | 171596-29-5 |
|---|---|
| Molecular Formula | C22H19N3O4 |
| Molecular Weight | 389.4 g/mol |
| Synonyms | (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tadalafil is a selective phosphodiesterase-5 inhibitor that is used to treat erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.
The listed CAS number is 171596-29-5.
The listed molecular formula is C22H19N3O4.
The listed molecular weight is 389.4 g/mol.
(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione.
The source lists Cialis and Tadalafil mylan.